| Literature DB >> 32435400 |
Serena Della Volpe1,2, Roberta Listro1, Michela Parafioriti1, Marcello Di Giacomo1, Daniela Rossi1, Francesca Alessandra Ambrosio3, Giosuè Costa3,4, Stefano Alcaro3,4, Francesco Ortuso3,4, Anna K H Hirsch5,6, Francesca Vasile2, Simona Collina1.
Abstract
The Hu family of RNA-binding proteins plays a crucial role in post-transcriptional processes; indeed, Hu-RNA complexes are involved in various dysfunctions (i.e., inflammation, neurodegeneration, and cancer) and have been recently proposed as promising therapeutic targets. Intrigued by this concept, our research efforts aim at identifying small molecules able to modulate HuR-RNA interactions, with a focus on subtype HuR, upregulated and dysregulated in several cancers. By applying structure-based design, we had already identified racemic trans-BOPC1 as promising HuR binder. In this Letter, we accomplished the enantio-resolution, the assignment of the absolute configuration, and the recognition study with HuR of enantiomerically pure trans-BOPC1. For the first time, we apply DEEP (differential epitope mapping)-STD NMR to study the interaction of BOPC1 with HuR and compare its enantiomers, gaining information on ligand orientation and amino acids involved in the interaction, and thus increasing focus on the in silico binding site model.Entities:
Year: 2020 PMID: 32435400 PMCID: PMC7236254 DOI: 10.1021/acsmedchemlett.9b00659
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345